Headache Disorders, Secondary
"Headache Disorders, Secondary" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Conditions with HEADACHE symptom that can be attributed to a variety of causes including BRAIN VASCULAR DISORDERS; WOUNDS AND INJURIES; INFECTION; drug use or its withdrawal.
| Descriptor ID |
D051271
|
| MeSH Number(s) |
C10.228.140.546.699
|
| Concept/Terms |
Headache Disorders, Secondary- Headache Disorders, Secondary
- Disorder, Secondary Headache
- Disorders, Secondary Headache
- Headache Disorder, Secondary
- Secondary Headache Disorder
- Secondary Headache Disorders
Analgesic Overuse Headache- Analgesic Overuse Headache
- Analgesic Overuse Headaches
- Headache, Analgesic Overuse
- Headaches, Analgesic Overuse
- Medication Overuse Headache
- Headache, Medication Overuse
- Headaches, Medication Overuse
- Medication Overuse Headaches
- Overuse Headache, Medication
- Overuse Headaches, Medication
Analgesic Rebound Headache- Analgesic Rebound Headache
- Analgesic Rebound Headaches
- Headache, Analgesic Rebound
- Headaches, Analgesic Rebound
|
Below are MeSH descriptors whose meaning is more general than "Headache Disorders, Secondary".
Below are MeSH descriptors whose meaning is more specific than "Headache Disorders, Secondary".
This graph shows the total number of publications written about "Headache Disorders, Secondary" by people in this website by year, and whether "Headache Disorders, Secondary" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2008 | 0 | 1 | 1 |
| 2019 | 0 | 1 | 1 |
| 2020 | 1 | 0 | 1 |
| 2021 | 1 | 0 | 1 |
| 2022 | 2 | 0 | 2 |
| 2023 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Headache Disorders, Secondary" by people in Profiles.
-
Starling AJ, Cowan RP, Buse DC, Diener HC, Marmura MJ, Hirman J, Brevig T, Cady R. Eptinezumab improved patient-reported outcomes in patients with migraine and medication-overuse headache: Subgroup analysis of the randomized PROMISE-2 trial. Headache. 2023 02; 63(2):264-274.
-
Cowan RP, Marmura MJ, Diener HC, Starling AJ, Schim J, Hirman J, Brevig T, Cady R. Quantity changes in acute headache medication use among patients with chronic migraine treated with eptinezumab: subanalysis of the PROMISE-2 study. J Headache Pain. 2022 Sep 06; 23(1):115.
-
Schwedt TJ, Hentz JG, Sahai-Srivastava S, Murinova N, Spare NM, Treppendahl C, Martin VT, Birlea M, Digre K, Watson D, Leonard M, Robert T, Dodick DW. Patient-Centered Treatment of Chronic Migraine With Medication Overuse: A Prospective, Randomized, Pragmatic Clinical Trial. Neurology. 2022 04 05; 98(14):e1409-e1421.
-
Marmura MJ, Diener HC, Cowan RP, Tepper SJ, Diamond ML, Starling AJ, Hirman J, Mehta L, Brevig T, Cady R. Preventive migraine treatment with eptinezumab reduced acute headache medication and headache frequency to below diagnostic thresholds in patients with chronic migraine and medication-overuse headache. Headache. 2021 10; 61(9):1421-1431.
-
Diener HC, Marmura MJ, Tepper SJ, Cowan R, Starling AJ, Diamond ML, Hirman J, Mehta L, Brevig T, Sperling B, Cady R. Efficacy, tolerability, and safety of eptinezumab in patients with a dual diagnosis of chronic migraine and medication-overuse headache: Subgroup analysis of PROMISE-2. Headache. 2021 Jan; 61(1):125-136.
-
Marmura MJ, Hou A. Inpatient Management of Migraine. Neurol Clin. 2019 11; 37(4):771-788.
-
Marmura MJ, Passero FC, Young WB. Mexiletine for refractory chronic daily headache: a report of nine cases. Headache. 2008 Nov-Dec; 48(10):1506-10.